Navigation Links
Full Year 2007 Results Date Notification - 21 February 2008
Date:2/12/2008

BASINGSTOKE, England and PHILADELPHIA, February 12 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY)(TSX: SHQ), the global specialty biopharmaceutical company, will announce full year 2007 earnings on Thursday 21 February 2008.

Results press release will be issued at: 12:00 GMT / 07:00 EST

Investor meeting and conference call time: 14:00 GMT / 09:00 EST

Investor & Analyst meeting and conference call:

Matthew Emmens, Chief Executive Officer, Angus Russell, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Gregoire, President, Human Genetic Therapies will host the investor and analyst meeting and conference call at 14:00 GMT/9:00 EST.

The meeting will take place at the offices of Deutsche Bank, Winchester House, 1 Great Winchester Street, London, EC2N 2DB.

Please email ssalah@shire.com to register to attend this meeting in London.
The details of the conference call are as follows:

UK dial in: 0800-953-0934

US dial in: 1866-224-2843

International dial in: +44-(0)1452-569-102

Password/Conf ID: 34394878

Live Webcast:* http://gaia.world-television.com/shire/20080221

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for one year. Details are as follows:

UK dial in 0800-953-1533

US dial in 1866-247-4222

International dial in +44-(0)1452-55-00-00

Pin code 34394878 #

Webcast replay:*

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...estigational sustained follicle stimulant achieves...in beta given over a one week period in Phase III ...ll/ -- Schering-Plough Corp., (NYSE: SGP ) today...cal trial demonstrating that a single injection of...ined follicle stimulants, achieved similar efficac...
(Date:7/1/2009)...ly 1 Peregrine Pharmaceu...t it has been awarded a European patent for a nove... to labels for diagnostic and therapeutic applicat...abeling, was developed for the production of radio...to other agents as well. A study published today ...
(Date:6/30/2009)...summer grass that tickles your feet or the red Bor...of the world around you carries special chemical m...cientists where the molecules that compose a subst...ned to them along the way. But doing these analyse...sts have developed a new method to make isotopic a...
(Date:6/30/2009)...RNewswire-FirstCall/ -- VEGA PROMOTIONAL SYSTEMS, ...osen Chattanooga, TN based consulting firm, Tennes...uilding a biomass production facility in Georgia. ...build a biomass plant in Georgia to take advantage...e,s Bioenergy Corridor. Georgia ranks third in th...
Breaking Biology Technology:Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4Stanford researchers find a quicker, cheaper way to sort isotopes 2Stanford researchers find a quicker, cheaper way to sort isotopes 3Vega Picks Tennessee Firm to Assist with Construction of Biomass Plant in Georgia 2
...Single-tube amplification method for high-throughp...Beti Belachew Peter Pingerelli ,Melanie Palmer ...uces the HSVision molecular beacon detection,mod...kly detect HSV (herpes simplex virus) DNA. Because...uires no postamplification,manipulation, HSV det...
...High-level expression of heterologous proteins ,... Waesche, Ronda Allen ,Stratagene , Codon bi...ion of,heterologous genes in E. coli hosts. In G...odons (AGG or AGA) and the proline codon (CCC) mos...or such situations, Stratagene introduces,BL21-C...
...High-fidelity PCR of genomic targets up to 19 kb ...uTurbo DNA,Polymerase , Michael Borns Holly...f long targets with PfuTurbo ,DNA polymerase* b...nditions. In this update, we describe adjustments ...ied up to 19 kb in length. , Superior accuracy a...
...tional tools for neuroscience researchers , .... Browning, Mary Ellen Simcox ,Stratagene Clon...ng gene-specific primer sets for the rat and human...ng these primers in reverse,transcriptase-mediat...ow,expression of NMDA subunits with Stratagenes ...
Other Biology Technology:HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 2HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 3HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex,Virus DNA 4New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 2New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 3New BL21-CodonPlus Cells Correct Codon Bias in GC-Rich Genomes 4Enhanced Amplification of Long Targets with PfuTurbo DNA,Polymerase 2Enhanced Amplification of Long Targets with PfuTurbo DNA,Polymerase 3Gene-Specific Primers for NMDA Receptor Subunits 2Gene-Specific Primers for NMDA Receptor Subunits 3Gene-Specific Primers for NMDA Receptor Subunits 4
(Date:7/1/2009)... European Molecular Biology Laboratory,s European ...a major new e-science resource for biologists whi...1N1 flu and cancer. , Biocatalogue.org , a cent...ces, is being officially launched today (Wednesday...ce on Intelligent Systems for Molecular Biology an...
(Date:7/1/2009)...s from across the United States and Russia are dep... Russian Arctic. The program, known as The Polaris...earch and education, and informing the public abou...Holmes, an associate scientist at the Woods Hole R..., says, "The Arctic is central to the global clima...
(Date:7/1/2009)...first time, scientists have shown that chromosomal... embryos, even those produced by young, fertile co...entre for Human Genetics and the University Fertil...5th annual conference of the European Society of H...July 1), that the surprising finding meant that cu...
(Date:6/30/2009)...e shown that if elderly men were given growth horm... muscle mass increase. Dr. Geoff Goldspink (Royal ...ys: "This raises the question: Can age-related los...eliorated by the therapeutic application of mechan...n also help sufferers of diseases such as muscular...
Breaking Biology News(10 mins):New e-science service could accelerate cancer research 2International team of students and scientists on month-long field course in Siberian Arctic 2International team of students and scientists on month-long field course in Siberian Arctic 3Chromosomal problems affect nearly all human embryos 2Chromosomal problems affect nearly all human embryos 3QUMAS and Datafarm Integration for end to end Electronic Submissions 41869 1QUMAS and Datafarm Integration for end to end Electronic Submissions 41869 2Oncolytics Biotech 28R 29 Inc Announces Positive Results of U K Phase II REOLYSIN 28R 29 and Radiation Combination Clinical Trial 11418 1Oncolytics Biotech 28R 29 Inc Announces Positive Results of U K Phase II REOLYSIN 28R 29 and Radiation Combination Clinical Trial 11418 2Oncolytics Biotech 28R 29 Inc Announces Positive Results of U K Phase II REOLYSIN 28R 29 and Radiation Combination Clinical Trial 11418 3Watson Announces United States Availability of RAPAFLO 28TM 29 28silodosin 29 a Novel New Treatment in Benign Prostatic Hyperplasia 28BPH 29 4134 1Watson Announces United States Availability of RAPAFLO 28TM 29 28silodosin 29 a Novel New Treatment in Benign Prostatic Hyperplasia 28BPH 29 4134 2Watson Announces United States Availability of RAPAFLO 28TM 29 28silodosin 29 a Novel New Treatment in Benign Prostatic Hyperplasia 28BPH 29 4134 3Watson Announces United States Availability of RAPAFLO 28TM 29 28silodosin 29 a Novel New Treatment in Benign Prostatic Hyperplasia 28BPH 29 4134 4Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients 4133 1Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients 4133 2Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients 4133 3Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients 4133 4
...es developed by computer may sound unnerving but t...velopment of new vaccines could bring new products...saving pharmaceutical companies millions of pounds...elling can help scientists to uncover and harness ...in sequences that modern bioscience generates and ...
...c. (Nasdaq: AFFX), announced today the launch of t...iated protocol developed in conjunction with PreAn...daq: QGEN; Frankfurt, Prime Standard: QIA) and BD ...mize the PreAnalytiX PAXgene(TM) Blood RNA System ...prove gene expression profile results of cellular ...
...ian first, UNSW researchers have developed three c...cells. The breakthrough could lead to new treatmen...rd injury. , "This cloning of cells involves a new...ting and then growing a single cell," said UNSW Se...research and is based at the Diabetes Transplant U...
...ass extinction in Earth history some 251 million y... before the main event and was followed by a delay... research by two University of Washington scientis...ygen levels was likely a major reason for both the...ery. , Earth,s land at the time was still massed i...
Other Biology News:Designing vaccines by computer 2Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX 2Affymetrix Launches New Globin-Reduction Kits and Protocol Developed with PreAnalytiX 3Stem cell research - new cell lines 2Low oxygen likely made Great Dying worse, greatly delayed recovery 2Low oxygen likely made Great Dying worse, greatly delayed recovery 3
...39;s NIS-Elements revolutionizes imaging software ...ntelligence to microscopes, cameras, components an...isualization and achiving tools. Its intuitive int...uisition times while providing powerful features s...
GC-RICH PCR System from Roche Applied Science
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine.
...ens ProteinChip System, Series 4000 incorporates t...nical researchers and biologists in biomarker rese...e, offering the fastest route for converting bioma...me platform. The Series 4000 is designed to fit in...
Biology Products: